FDMT - 4D Molecular Therapeutics Inc
IEX Last Trade
15.04
-0.210 -1.396%
Share volume: 418,309
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$15.25
-0.21
-1.38%
Summary score
15%
Profitability
18%
Dept financing
2%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.48%
Return on assets
-8.12%
Return on sales
-996.72%
Return on invested capital
-34.13%
Total debt ratio
8.79%
Debt ratio change over timeo
-1.11%
Current Ratio
19.29%
Quick Ratio
19.29%
Cash Position Ratio
18.82%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-7.02%
Return on assets
-7.45%
Return on sales
13475.37%
Return on invested capital
-95.7%
Total debt ratio
7.65%
Debt ratio change over timeo
-1.09%
Current Ratio
22.37%
Quick Ratio
22.37%
Cash Position Ratio
21.86%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-5.4%
Return on assets
-6.05%
Return on sales
-136200%
Return on invested capital
-41.6%
Total debt ratio
4.66%
Debt ratio change over time
-1.04%
Current Ratio
32.65%
Quick Ratio
32.65%
Cash Position Ratio
32.06%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-88.9%
Return on assets
-89.37%
Return on sales
-21354.63%
Return on invested capital
-63.65%
Total debt ratio
-111.4%
Debt ratio change over time
-1.11%
Current Ratio
-25.86%
Quick Ratio
-25.86%
Cash Position Ratio
-25.23%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FDMT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -8.48% | 13.79% | 34.47% | 7.43% |
| Return on assets | -8.12% | 2.76% | 3.15% | 5.62% |
| Return on sales | -996.72% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -34.13% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 8.79% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.11% | 308.97% | -6.99% | 1.18% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 22.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 22.37% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 21.86% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 3% | 6% | 13% |
| Short-term ratios | FDMT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -7.02% | 13.77% | 13.25% | 3.8% |
| Return on assets | -7.45% | 2.43% | 1.89% | 3.09% |
| Return on sales | 13475.37% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -95.7% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 51% | 49% | 57% |
| Total debt ratio | 7.65% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.09% | 46.38% | -72.08% | 1.51% |
| Dept financing | 2% | 50% | 25% | 7% |
| Current Ratio | 22.37% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 22.37% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 21.86% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 2% | 6% | 15% |